Dureja H - Search Results

1

An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery.

Kumar V, Garg V, Saini N, Aggarwal N, Kumar H, Kumar D, Chopra H, Kamal MA, Dureja H. Kumar V, et al. Among authors: dureja h. Curr Pharm Biotechnol. 2024;25(17):2218-2252. doi: 10.2174/0113892010267771240211124950. Curr Pharm Biotechnol. 2024. PMID: 38415490 Review.

2

Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.

Pandey P, Chellappan DK, Tambuwala MM, Bakshi HA, Dua K, Dureja H. Pandey P, et al. Among authors: dureja h. Int J Biol Macromol. 2019 Dec 1;141:596-610. doi: 10.1016/j.ijbiomac.2019.09.023. Epub 2019 Sep 5. Int J Biol Macromol. 2019. PMID: 31494160

3

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Prasher P, Sharma M, Mehta M, Paudel KR, Satija S, Chellappan DK, Dureja H, Gupta G, Tambuwala MM, Negi P, Wich PR, Hansbro NG, Hansbro PM, Dua K. Prasher P, et al. Among authors: dureja h. Chem Biol Interact. 2020 Jul 1;325:109125. doi: 10.1016/j.cbi.2020.109125. Epub 2020 May 4. Chem Biol Interact. 2020. PMID: 32376238 Free PMC article. Review.

4

Simulation of skin permeability in chitosan membranes.

Dureja H, Tiwary AK, Gupta S. Dureja H, et al. Int J Pharm. 2001 Feb 1;213(1-2):193-8. doi: 10.1016/s0378-5173(00)00666-9. Int J Pharm. 2001. PMID: 11165107

5

Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease.

Gupta G, Dahiya R, Singh Y, Mishra A, Verma A, Gothwal SK, Aljabali AAA, Dureja H, Prasher P, Negi P, Kapoor DN, Goyal R, Tambuwala MM, Chellappan DK, Dua K. Gupta G, et al. Among authors: dureja h. Chem Biol Interact. 2020 Feb 1;317:108975. doi: 10.1016/j.cbi.2020.108975. Epub 2020 Feb 4. Chem Biol Interact. 2020. PMID: 32032593 Review.

6

Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update.

Mehta M, Dhanjal DS, Paudel KR, Singh B, Gupta G, Rajeshkumar S, Thangavelu L, Tambuwala MM, Bakshi HA, Chellappan DK, Pandey P, Dureja H, Charbe NB, Singh SK, Shukla SD, Nammi S, Aljabali AA, Wich PR, Hansbro PM, Satija S, Dua K. Mehta M, et al. Among authors: dureja h. Inflammopharmacology. 2020 Aug;28(4):795-817. doi: 10.1007/s10787-020-00698-3. Epub 2020 Mar 18. Inflammopharmacology. 2020. PMID: 32189104 Review.

7

Prediction of pharmacokinetic parameters.

Madan AK, Dureja H. Madan AK, et al. Among authors: dureja h. Methods Mol Biol. 2012;929:337-57. doi: 10.1007/978-1-62703-050-2_14. Methods Mol Biol. 2012. PMID: 23007436

8

Models for antitubercular activity of 5â-O-[(N-Acyl)sulfamoyl]adenosines.

Goyal RK, Dureja H, Singh G, Madan AK. Goyal RK, et al. Among authors: dureja h. Sci Pharm. 2010 Oct-Dec;78(4):791-820. doi: 10.3797/scipharm.1006-03. Epub 2010 Aug 13. Sci Pharm. 2010. PMID: 21179317 Free PMC article.

9

Formulation and evaluation of metformin oro-dispersible tablets.

Kamboj M, Goyal S, Rakha P, Arora G, Dureja H, Nagpal M. Kamboj M, et al. Among authors: dureja h. Acta Pol Pharm. 2011 Sep-Oct;68(5):717-23. Acta Pol Pharm. 2011. PMID: 21928717 Free article.

10

Topological models for prediction of physico-chemical, pharmacokinetic and toxicological properties of antihistaminic drugs using decision tree and moving average analysis.

Dureja H, Gupta S, Madan AK. Dureja H, et al. Int J Comput Biol Drug Des. 2009;2(4):353-70. doi: 10.1504/IJCBDD.2009.030766. Epub 2009 Jan 4. Int J Comput Biol Drug Des. 2009. PMID: 20090176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters